More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Steroidogenic Factor 1 antibody [N1665]

Steroidogenic Factor 1 antibody [N1665]

Research Use Only
GTX01827
GeneTex
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
DownloadDatasheet
Product group Antibodies
ReactivityHuman
TargetNR5A1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    Steroidogenic Factor 1 antibody [N1665]
  • Delivery Days Customer
    9
  • Application Supplier Note
    IHC-P: 1:50-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    N1665
  • Conjugate
    Unconjugated
  • Formulation
    Liquid
  • Gene ID2516
  • Target name
    NR5A1
  • Target description
    nuclear receptor subfamily 5 group A member 1
  • Target synonyms
    AD4BP; adrenal 4 binding protein; ELP; FTZ1; FTZF1; fushi tarazu factor homolog 1; hSF-1; nuclear receptor AdBP4; POF7; SF1; SF-1; SPGF8; SRXX4; SRXY3; steroid hormone receptor Ad4BP; steroidogenic factor 1; steroidogenic factor 1 nuclear receptor; steroidogenic factor-1; STF-1
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDQ13285
  • Protein Name
    Steroidogenic factor 1
  • Scientific Description
    The protein encoded by this gene is a transcriptional activator involved in sex determination. The encoded protein binds DNA as a monomer. Defects in this gene are a cause of XY sex reversal with or without adrenal failure as well as adrenocortical insufficiency without ovarian defect. [provided by RefSeq, Jul 2008]
  • Reactivity
    Human
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification. Colecchia M et al., 2021 Jan, Histopathology
    Read more
  • A Morphologic and Immunohistochemical Comparison of Nuclear beta-Catenin Expressing Testicular Sertoli Cell Tumors and Pancreatic Solid Pseudopapillary Neoplasms Supporting Their Continued Separate Classification. Kao CS et al., 2020 Aug, Am J Surg Pathol
    Read more
  • Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings. Tamanini JVG et al., 2020 Jun, Neurosurg Focus
    Read more
  • A Novel Dual Immunostain to Characterize Sloughed Cells in Testicular Biopsies for Infertility. Dhakal HP et al., 2019 Aug, Am J Surg Pathol
    Read more
  • Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease. Asa SL et al., 2019 Feb, Am J Surg Pathol
    Read more